1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Industry 2015 Market Research Report


The Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Biomarker Technology Platforms for Cancer Diagnoses and Therapies industry.

The report provides a basic overview of the industry including definitions and classifications. The Biomarker Technology Platforms for Cancer Diagnoses and Therapies market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information.

With 139 the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Basic Information of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
1.1.1 Definition of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
1.1.2 Classifications of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
1.1.2.1 Breast Cancer
1.1.2.2 Ovarian Cancer
1.1.2.3 Prostate Cancer
1.1.2.4 Bladder Cancer
1.1.2.5 Colorectal Cancer
1.1.2.6 Leukemia
1.1.2.7 Lung Cancer
1.1.3 Applications of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
1.1.4 Characteristics of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
1.2 Development Overview of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
1.3 Enter Barriers Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies

2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies International and China Market Analysis
2.1 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Industry International Market Analysis
2.1.1 Biomarker Technology Platforms for Cancer Diagnoses and Therapies International Market Development History
2.1.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Competitive Landscape Analysis
2.1.3 Biomarker Technology Platforms for Cancer Diagnoses and Therapies International Main Countries Development Status
2.1.4 Biomarker Technology Platforms for Cancer Diagnoses and Therapies International Market Development Trend
2.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Industry China Market Analysis
2.2.1 Biomarker Technology Platforms for Cancer Diagnoses and Therapies China Market Development History
2.2.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Competitive Landscape Analysis
2.2.3 Biomarker Technology Platforms for Cancer Diagnoses and Therapies China Main Regions Development Status
2.2.4 Biomarker Technology Platforms for Cancer Diagnoses and Therapies China Market Development Trend
2.3 Biomarker Technology Platforms for Cancer Diagnoses and Therapies International and China Market Comparison Analysis

3 Environment Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
3.1 International Economy Analysis
3.2 China Economy Analysis
3.3 Policy Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
3.4 News Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies

4 Analysis of Revenue by Classifications
4.1 Global Revenue of Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Classifications 2010-2015
4.2 Global Revenue Growth Rate of Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Classifications 2010-2015
4.3 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Classifications

5 Analysis of Revenue by Regions and Applications
5.1 Global Revenue of Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Regions 2010-2015
5.2 2010-2015 USA Revenue and Revenue Growth Rate of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
5.3 2010-2015 Europe Revenue and Revenue Growth Rate of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
5.4 2010-2015 Japan Revenue and Revenue Growth Rate of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
5.5 2010-2015 China Revenue and Revenue Growth Rate of Biomarker Technology Platforms for Cancer Diagnoses and Therapies

6 Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Status 2010-2015
6.1 Revenue of Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2010-2015
6.2 Revenue Market Share Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2010-2015
6.3 Revenue Overview of Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2010-2015
6.4 Gross Margin of Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2010-2015

7 Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies Industry Key Manufacturers
7.1 Abbott
7.1.1 Company Profile
7.1.2 Revenue and Gross Margin
7.1.3 Abbott SWOT Analysis

7.2 Affymetrix
7.2.1 Company Profile
7.2.2 Revenue and Gross Margin
7.2.3 Affymetrix SWOT Analysis

7.3 Agendia
7.3.1 Company Profile
7.3.2 Revenue and Gross Margin
7.3.3 Agendia SWOT Analysis

7.4 Agensys
7.4.1 Company Profile
7.4.2 Revenue and Gross Margin
7.4.3 Agensys SWOT Analysis

7.5 Agilent
7.5.1 Company Profile
7.5.2 Revenue and Gross Margin
7.5.3 Agilent SWOT Analysis

7.6 Almac Group
7.6.1 Company Profile
7.6.2 Revenue and Gross Margin
7.6.3 Almac Group SWOT Analysis

7.7 AMDL
7.7.1 Company Profile
7.7.2 Revenue and Gross Margin
7.7.3 AMDL SWOT Analysis

7.8 Asuragen
7.8.1 Company Profile
7.8.2 Revenue and Gross Margin
7.8.3 Asuragen SWOT Analysis

7.9 Beckman Coulter
7.9.1 Company Profile
7.9.2 Revenue and Gross Margin
7.9.3 Beckman Coulter SWOT Analysis

7.10 Biocode Hycel
7.10.1 Company Profile
7.10.2 Revenue and Gross Margin
7.10.3 Biocode Hycel SWOT Analysis

7.11 BioCurex
7.11.1 Company Profile
7.11.2 Revenue and Gross Margin
7.11.3 BioCurex SWOT Analysis

7.12 Biomarker Technologies
7.12.1 Company Profile
7.12.2 Revenue and Gross Margin
7.12.3 Biomarker Technologies SWOT Analysis

7.13 BDI
7.13.1 Company Profile
7.13.2 Revenue and Gross Margin
7.13.3 BDI SWOT Analysis

7.14 Biomerica
7.14.1 Company Profile
7.14.2 Revenue and Gross Margin
7.14.3 Biomerica SWOT Analysis

7.15 BioMerieux
7.15.1 Company Profile
7.15.2 Revenue and Gross Margin
7.15.3 bioMerieux SWOT Analysis

7.16 OncoThyreon
7.16.1 Company Profile
7.16.2 Revenue and Gross Margin
7.16.3 OncoThyreon SWOT Analysis

7.17 Biomoda
7.17.1 Company Profile
7.17.2 Revenue and Gross Margin
7.17.3 Biomoda SWOT Analysis

7.18 Bruker Daltonics
7.18.1 Company Profile
7.18.2 Revenue and Gross Margin
7.18.3 Bruker Daltonics SWOT Analysis

7.19 Byk Gulden
7.19.1 Company Profile
7.19.2 Revenue and Gross Margin
7.19.3 Byk Gulden SWOT Analysis

8 Sales Price and Gross Margin Analysis
8.1 Sales Price Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
8.2 Gross Margin Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies

9 Marketing Trader or Distributor Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
9.1 Marketing Channels Status of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
9.2 How Countries Meet Their Needs
9.2.1 USA
9.2.2 China
9.2.3 Japan
9.2.4 Germany

10 Development Trend of Biomarker Technology Platforms for Cancer Diagnoses and Therapies Industry 2016-2021
10.1 Revenue Overview of Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2016-2021
10.2 Sales Price Overview of Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2016-2021

11 Industry Chain Suppliers of Biomarker Technology Platforms for Cancer Diagnoses and Therapies with Contact Information
11.1 Equipment Suppliers of Biomarker Technology Platforms for Cancer Diagnoses and Therapies with Contact Information
11.2 Major Suppliers of Biomarker Technology Platforms for Cancer Diagnoses and Therapies with Contact Information
11.3 Key Consumers of Biomarker Technology Platforms for Cancer Diagnoses and Therapies with Contact Information
11.4 Supply Chain Relationship Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies

12 New Project Investment Feasibility Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
12.1 New Project SWOT Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
12.2 New Project Investment Feasibility Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies

13 Conclusion of the Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Industry 2015 Market Research Report



List of Tables and Figures
Table Classifications of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Table Applications of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Table Policy of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Table Industry News List of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Table Global Revenue of Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Classifications 2010-2015 (M USD)
Table Global Revenue Market Share of Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Classifications 2010-2015
Figure Global Revenue Market Share of Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Classifications in 2010
Figure Global Revenue Market Share of Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Classifications in 2015
Figure Global Revenue Growth Rate of Type One 2010-2015
Figure Global Revenue Growth Rate of Type Two 2010-2015
Figure Global Revenue Growth Rate of Type Three 2010-2015
Table USA Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Classifications
Table Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Classifications
Table Japan Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Classifications
Table China Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Classifications
Table Global Revenue of Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Regions 2010-2015 (M USD)
Table Global Revenue Market Share of Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Regions 2010-2015
Figure Global Revenue Market Share of Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Regions in 2010
Figure Global Revenue Market Share of Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Regions in 2015
Table USA Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Applications
Figure USA Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Revenue Growth Rate
Table Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Applications
Figure Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Revenue Growth Rate
Table Japan Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Applications
Figure Japan Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Revenue Growth Rate
Table China Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Applications
Figure China Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Revenue Growth Rate
Table Global and China Major Players Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue of 2010-2015 (M USD)
Table Global and China Major Players Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share of 2010-2015
Table China Major Players Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue of 2010-2015 (M USD)
Table China Major Players Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share of 2010-2015
Figure Global Revenue Market Share of Major Biomarker Technology Platforms for Cancer Diagnoses and Therapies Players in 2010
Figure Global Revenue Market Share of Major Biomarker Technology Platforms for Cancer Diagnoses and Therapies Players in 2015
Figure China Revenue Market Share Major Biomarker Technology Platforms for Cancer Diagnoses and Therapies Players in 2010
Figure China Revenue Market Share Major Biomarker Technology Platforms for Cancer Diagnoses and Therapies Players in 2015
Figure Global Revenue and Growth Rate of Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2010-2015
Figure China Revenue and Growth Rate of Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2010-2015
Figure 2010-2015 Global and China Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Comparison
Table Cost of Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Major Players 2010-2015 (M USD)
Table Gross of Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Major Players 2010-2015 (M USD)
Table Gross Margin of Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Major Players 2010-2015
Figure Gross Margin of Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Major Players in 2014
Table Company Profile List of Abbott
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Abbott 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Abbott 2010-2015
Table SWOT Analysis of Abbott 2010-2015
Table Company Profile List of Affymetrix
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Affymetrix 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Affymetrix 2010-2015
Table SWOT Analysis of Affymetrix 2010-2015
Table Company Profile List of Agendia
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Agendia 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Agendia 2010-2015
Table SWOT Analysis of Agendia 2010-2015
Table Company Profile List of Agensys
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Agensys 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Agensys 2010-2015
Table SWOT Analysis of Agensys 2010-2015
Table Company Profile List of Agilent
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Agilent 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Agilent 2010-2015
Table SWOT Analysis of Agilent 2010-2015
Table Company Profile List of Almac Group
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Almac Group 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Almac Group 2010-2015
Table SWOT Analysis of Almac Group 2010-2015
Table Company Profile List of AMDL
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of AMDL 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of AMDL 2010-2015
Table SWOT Analysis of AMDL 2010-2015
Table Company Profile List of Asuragen
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Asuragen 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Asuragen 2010-2015
Table SWOT Analysis of Asuragen 2010-2015
Table Company Profile List of Beckman Coulter
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Beckman Coulter 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Beckman Coulter 2010-2015
Table SWOT Analysis of Beckman Coulter 2010-2015
Table Company Profile List of Biocode Hycel
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Biocode Hycel 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Biocode Hycel 2010-2015
Table SWOT Analysis of Biocode Hycel 2010-2015
Table Company Profile List of BioCurex
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of BioCurex 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of BioCurex 2010-2015
Table SWOT Analysis of BioCurex 2010-2015
Table Company Profile List of Biomarker Technologies
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Biomarker Technologies 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Biomarker Technologies 2010-2015
Table SWOT Analysis of Biomarker Technologies 2010-2015
Table Company Profile List of BDI
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of BDI 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of BDI 2010-2015
Table SWOT Analysis of BDI 2010-2015
Table Company Profile List of Biomerica
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Biomerica 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Biomerica 2010-2015
Table SWOT Analysis of Biomerica 2010-2015
Table Company Profile List of bioMerieux
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of bioMerieux 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of bioMerieux 2010-2015
Table SWOT Analysis of bioMerieux 2010-2015
Table Company Profile List of OncoThyreon
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of OncoThyreon 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of OncoThyreon 2010-2015
Table SWOT Analysis of OncoThyreon 2010-2015
Table Company Profile List of Biomoda
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Biomoda 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Biomoda 2010-2015
Table SWOT Analysis of Biomoda 2010-2015
Table Company Profile List of Bruker Daltonics
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Bruker Daltonics 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Bruker Daltonics 2010-2015
Table SWOT Analysis of Bruker Daltonics 2010-2015
Table Company Profile List of Byk Gulden
Table Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Byk Gulden 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate of Byk Gulden 2010-2015
Table SWOT Analysis of Byk Gulden 2010-2015
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Manufactor Profit Model
Figure Marketing Channels Status of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Figure Global Revenue and Growth Rate of Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2016-2021
Figure China Revenue and Growth Rate of Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2016-2021
Figure Global and China Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Comparison 2016-2021
Table Equipment Suppliers of Biomarker Technology Platforms for Cancer Diagnoses and Therapies with Contact Information
Table Major Suppliers of Biomarker Technology Platforms for Cancer Diagnoses and Therapies with Contact Information
Table Key Consumers of Biomarker Technology Platforms for Cancer Diagnoses and Therapies with Contact Information
Figure Supply Chain Relationship Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Table New Project SWOT Analysis of Biomarker Technology Platforms for Cancer Diagnoses and Therapies

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Biobanking: Technologies and Global Markets

Biobanking: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Analyze the role biobanks play in the development of new drugs for specific disease treatments. - Learn about the prevailing market size for certain biobank services available ...

Cardiac Biomarkers Market By Type, By Application, By End Use, By Region And Segment Forecasts to 2024

Cardiac Biomarkers Market By Type, By Application, By End Use, By Region And Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

The cardiac biomarkers market is expected to reach USD13.3 billion by 2024, according to a new report by Grand View Research, Inc. The cardiac biomarkers market is anticipated to witness a lucrative growth ...

Cancer Biomarkers - Global Market Outlook (2016-2022)

Cancer Biomarkers - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by 2022 growing at a CAGR of 12.5% from 2015 to 2022. ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.